Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Merli

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Hematological Oncology|April 25, 2024
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experienceVittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, et al.
International Journal of Cancer|January 10, 2009
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infectionLuca Arcaini, Cristiana Pascutto, Francesco Passamonti, et al.
International Journal of Molecular Sciences|May 13, 2023
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical FormsSara Fraticelli, Marco Lucioni, Giuseppe Neri, et al.
Hematological Oncology|February 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life StudyLucia Farina, Alessandro Noto, Antonella Aiello, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphomaLuca Arcaini, Marzia Varettoni, Emanuela Boveri, et al.
Hematological Oncology|November 5, 2020
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomasMichele Merli, Dario Marino, Emanuele Cencini, et al.
Haematologica|May 15, 2025
Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamabGianluigi Ardissino, Piera Angelillo, Maria Cristina Mancuso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern ItalyLuca Arcaini, Sara Burcheri, Andrea Rossi, et al.
American Journal of Hematology|December 4, 2009
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomasLuca Arcaini, Michele Merli, Francesco Passamonti, et al.
Ejhaem|November 10, 2025
Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian CohortCaterina Cristinelli, Michele Merli, Marco Lucioni, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Hematological Oncology|April 25, 2024
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experienceVittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, et al.
International Journal of Cancer|January 10, 2009
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infectionLuca Arcaini, Cristiana Pascutto, Francesco Passamonti, et al.
International Journal of Molecular Sciences|May 13, 2023
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical FormsSara Fraticelli, Marco Lucioni, Giuseppe Neri, et al.
Hematological Oncology|February 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life StudyLucia Farina, Alessandro Noto, Antonella Aiello, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphomaLuca Arcaini, Marzia Varettoni, Emanuela Boveri, et al.
Hematological Oncology|November 5, 2020
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomasMichele Merli, Dario Marino, Emanuele Cencini, et al.
Haematologica|May 15, 2025
Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamabGianluigi Ardissino, Piera Angelillo, Maria Cristina Mancuso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern ItalyLuca Arcaini, Sara Burcheri, Andrea Rossi, et al.
American Journal of Hematology|December 4, 2009
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomasLuca Arcaini, Michele Merli, Francesco Passamonti, et al.
Ejhaem|November 10, 2025
Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian CohortCaterina Cristinelli, Michele Merli, Marco Lucioni, et al.
Pageof 12